Data from Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity
Bangxing Hong(Augusta University Health), Balveen Kaur(Augusta University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Karuppaiyah Selvendiran(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Yuanqing Yan(Northwestern University), Guangsheng Pei(The University of Texas Health Science Center), Valerie Chapa(The University of Texas MD Anderson Cancer Center), David E. Cohn(The Ohio State University), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Guangan He(The University of Texas MD Anderson Cancer Center), Uksha Saini(Ohio State University Hospital), Puneet Modgil, Zahid H. Siddik, Zhongming Zhao(Vanderbilt University)
Cited by 0
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
|Cell Reports|2018|1.3k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822